"If some significant fraction of the NIH budget is going to large-scale projects, and a substantial fraction of each project's budget goes into informatics, that translates into a lot of jobs." --David States, professor of bioinformatics, University of Washington
I knew a little molecular biology, but I had no notion of what you could do experimentally. It reminded me of electronics, the idea that you had these tools to splice things together in an ordered way, that you could reengineer things in the cell to do something else. --Mark Goulian
Malik goes to seminars to learn not just what they're doing, but how they're approaching questions. "It's really exciting to see how this person went about developing the story and making these connections . . . It's really useful to see how a scientific mind thinks about a particular problem."
"It is definitely an asset to work with more than one system. It opens us up to different ways of thinking and keeps us flexible and less likely to sink into dogma. The differences in how the various systems are wired are as important as the similarities." --Sabeeha Merchant, University of Wisconsin, Madison.
"The focus isn’t because this is cheap. In fact logistically, it’s quite a challenge to do this. Whether you’re AstraZeneca, or Roche, or Novartis, you have to pay quite a bit to have that presence. Our focus is to have a presence in China, for China, and for the rest of Asia." --John Ramsey, AstraZeneca
"There isn't a pharmaceutical company that doesn't want these people. [Fellowship participants] are getting calls from headhunters 6 months or a year before they've finished." --Dave Flockhart, professor of medicine, Indiana University School of Medicine